α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 31 março 2025

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Updates in the function and regulation of α1‐adrenoceptors - Akinaga - 2019 - British Journal of Pharmacology - Wiley Online Library

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Targeting of G-protein coupled receptors in sepsis - ScienceDirect

Crystal structure of the α1B-adrenergic receptor reveals molecular determinants of selective ligand recognition

Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio - ScienceDirect

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Alpha-1-adrenergic receptors: Targets for agonist drugs to treat heart failure - Journal of Molecular and Cellular Cardiology

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

SciELO - Brasil - Neurohumoral activation in heart failure: the role of adrenergic receptors Neurohumoral activation in heart failure: the role of adrenergic receptors

Adrenergic Nervous System in Heart Failure

Recomendado para você